top of page
Recobia Tx
Is developing an innovative platform of biocompatible, biodegradable polysaccharide-based hydrocolloid gels for the controlled subcutaneous release of therapeutic antibodies and ADCs. This approach aims to make biological cancer treatments more accessible by facilitating rapid, convenient subcutaneous administration for patients and hospitals.
PSCC's entrance
Décembre 2025
Localization
FR - Grand Est
Modality
Targeted therapy
Development status
Biotech - Lead optimization
Lauréat (s)
bottom of page



